Top Medical News

Venetoclax/Obinutuzumab Continues to Show Efficacy in Unfit Patients with CLL

June 30th 2022

An updated safety and efficacy analysis of the ongoing CLL14 trial showed that venetoclax plus obinutuzumab continues to be an effective treatment for patients with chronic lymphocytic leukemia and coexisting conditions.

Oncology Nursing News Top Stories: June 2022

June 30th 2022

Each month, we take a look back at the most popular Oncology Nursing News® stories. Here are the top 5 stories from June 2022.

Expanded Safety Analysis from CheckMate 648 Shows Tolerability with Frontline Nivolumab Combinations in ESCC

June 29th 2022

Data from the CheckMate 648 trial informed the FDA’s recent approval of 2 nivolumab combinations for esophageal squamous cell carcinoma. A 1-year follow-up analysis highlighted key safety and time-to-event data surrounding immune-related toxicities.

Virtual Planning For Surgical Reconstruction May Improve Outcomes for Patients With Head and Neck Cancer

June 29th 2022

Mandible reconstruction and maxilla reconstruction surgeries might be optimized with virtual surgical planning, according to an expert speaker at the 2022 Supportive Care in Cancer Annual Meeting.

Oncology Nursing News’ Top ASCO Picks

June 28th 2022

We rounded up 5 stories from the 2022 ASCO Annual Meeting that are of most value to oncology nurses.

Most Recent